GPX4 and lung carcinoma: Apart from natural compounds, some drugs that have been marketed (Table 1) such as Vorinostat (Zhang T. et al., 2021), Orlistat (Zhou W. et al., 2021) have also been found to act as ferroptosis inducers in lung cancer cells via inhibiting System Xc−/GSH/GPX4 axis.